Fragility of progress: how U.S. foreign aid disruptions threaten HIV/AIDS control in Sub-Saharan Africa

Through the President's Emergency Plan for AIDS Relief and United States Agency for International Development, the United States has made significant contributions to global HIV/AIDS response, investing over 100 billion and saving an estimated 26 million lives over two decades, mostly in sub-Saharan Africa. The 2025 executive order freezing U. S. foreign aid threatens to undo decades of progress. This perspective paper appraises the consequences of this policy shift, highlighting the potential dire public health, economic, and geopolitical consequences; and proposes sustainable mitigation strategies. The immediate effects include interruptions of antiretroviral therapy (ART). Prediction models indicate interruptions of ART may result in over 500, 000 additional deaths in South Africa alone and one million new pediatric HIV infections in Sub-Saharan Africa. Health systems are already being destabilized by supply chain disruptions, closures of clinic, and health workforce layoffs. Prevention programs are in danger of collapsing, risking a resurgence in transmission rates. Long−term consequences include economic losses, erosion of research capacity, and geopolitical shifts as China and others fill the vacuum left by the U. S. retreat. This crisis underscores the fragility of aid-dependent systems. Sustainable solutions demand that Africa show leadership through domestic resource mobilization, regional collaboration, and diversified partnerships. Without intervention, the world faces a return to early-2000s AIDS mortality levels. Policy recommendations include interim multilateral funding, accelerated African financing mechanisms, and global advocacy to reinstate U. S. support. The stakes are existential as millions of lives hinge on bridging this gap between aid dependency and health sovereignty.